Dr. Wyssem A. Ramdani, MD

Dr. Ramdani practices at Ascension Via Christi St. Francis in Wichita, Kansas, part of Ascension Health Alliance.

Dr. Ramdani's NPI, 1104840693, was assigned on July 27, 2006. Dr. Ramdani holds Arizona license 42149.

Dr. Ramdani's primary practice is Ascension Via Christi St. Francis, at 929 North St Francis Street, Wichita, KS 67214 in Sedgwick County. The practice phone is (316) 268-5000.

Dr. Ramdani's primary practice is Ascension Via Christi St. Francis in Wichita, Kansas, part of Ascension Health Alliance. Dr. Ramdani is also affiliated with Ascension Via Christi St. Teresa. The medical group on file is Ascension Medical Group Via Christi. Dmand AI also links Dr. Ramdani to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramdani practices, 7 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ramdani's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Ramdani's licenses on file in 2 states: Arizona and Michigan.

CMS data shows 856 Medicare services from Dr. Ramdani across 4 procedure codes in 2024, for 307 Medicare patients. Medicare paid $110,369 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 307 Medicare patients who saw Dr. Ramdani in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramdani's median patient age at 75, with 56% women.

In 2020, Dr. Ramdani wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $85 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ramdani for performance year 2024, reported as part of a group. Dr. Ramdani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Dr. Ramdani from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $199.